ID: ALA5274231

Max Phase: Preclinical

Molecular Formula: C17H15NS

Molecular Weight: 265.38

Associated Items:

Representations

Canonical SMILES:  c1ccc(-c2c(-c3cccs3)cn3c2CCC3)cc1

Standard InChI:  InChI=1S/C17H15NS/c1-2-6-13(7-3-1)17-14(16-9-5-11-19-16)12-18-10-4-8-15(17)18/h1-3,5-7,9,11-12H,4,8,10H2

Standard InChI Key:  PRFLTDYOAMOLAD-UHFFFAOYSA-N

Associated Targets(Human)

Arachidonate 5-lipoxygenase 6568 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 265.38Molecular Weight (Monoisotopic): 265.0925AlogP: 4.83#Rotatable Bonds: 2
Polar Surface Area: 4.93Molecular Species: HBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.60CX LogD: 4.60
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.63Np Likeness Score: -1.05

References

1. Gouda AM, Abdelazeem AH..  (2016)  An integrated overview on pyrrolizines as potential anti-inflammatory, analgesic and antipyretic agents.,  114  [PMID:26994693] [10.1016/j.ejmech.2016.01.055]

Source